Cargando…
Targeting Multiple End Organs in Lupus and Other Systemic Rheumatic Diseases by Inhibiting Bruton’s Tyrosine Kinase
Bruton tyrosine kinase (Btk) plays a vital role in activating and differentiating B-cells and regulating signaling in myeloid cells. Indeed, the potential use of Btk inhibitors in preventing lupus has been reported. Here, we extend these observations to 4 additional models of end-organ inflammation:...
Autores principales: | Du, Yong, Lei, Ling, Ding, Huihua, Chen, Yanping, Pathak, Simanta, Hicks, John, Tran, Phuongthy T., Wu, Minghua, Chang, Betty, Wirtz, Uwe, Mohan, Chandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304663/ https://www.ncbi.nlm.nih.gov/pubmed/35874767 http://dx.doi.org/10.3389/fimmu.2022.893899 |
Ejemplares similares
-
Cellular and molecular pathogenesis of systemic lupus erythematosus: lessons from animal models
por: Pathak, Simanta, et al.
Publicado: (2011) -
Bruton's tyrosine kinase: oncotarget in myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2012) -
Editorial: Targeting Bruton Tyrosine Kinase
por: Brunner, Cornelia, et al.
Publicado: (2022) -
Targeting Bruton’s Tyrosine Kinase in CLL
por: Ahn, Inhye E., et al.
Publicado: (2021) -
Highly selective inhibition of Bruton’s tyrosine kinase attenuates skin and brain disease in murine lupus
por: Chalmers, Samantha A., et al.
Publicado: (2018)